Asosiy kontentga oʻtish
Boshqa

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

Jay AcharImperial College London, LondonCatherine BerryMédecins Sans Frontières, Tashkent, UzbekistanKrzysztof HerboczekMédecins Sans Frontières, Tashkent, UzbekistanNargiza ParpievaImperial College London, LondonMirzagaleb TillyashaykhovMinistry of Health, Tashkent (N. Parpieva, M.N. Tillyashaykhov); Ministry of Health, Nukus, UzbekistanZinaida TigayMédecins Sans Frontières, London, UKAtadjan KhamraevMinistry of Health, Tashkent (N. Parpieva, M.N. Tillyashaykhov); Ministry of Health, Nukus, UzbekistanKalyan VelivelaMédecins Sans Frontières, London, UKJames A. SeddonMinistry of Health, Tashkent (N. Parpieva, M.N. Tillyashaykhov); Ministry of Health, Nukus, UzbekistanPhilipp du CrosMinistry of Health, Tashkent (N. Parpieva, M.N. Tillyashaykhov); Ministry of Health, Nukus, Uzbekistan
ABI

Annotatsiya

To the Editor: Approximately 480,000 persons ac-quired multidrug-resistant tuberculosis (MDR TB) in 2013 (1). Of the 32,000 children who acquire MDR TB annually, few are identified and administered appropriate treatment (2). World Health Organization (WHO)–recommended treatment for MDR TB lasts 20–24 months, including 8 months of daily drug injections (3). Because many children have paucibacillary TB, a shorter protocol may be suffi-cient, especially for early or nonsevere disease.

Hali tarjima qilinmagan

Mavzular

Identifikatorlar

Iqtiboslar va manbalar